logo

For the Inventor, By the Inventor

East Syracuse, NY, United States of America

Chester Sapino, Jr

This inventor holds 15 USPTO granted patents. Top assignees: Bristol-Myers Company, Bristol-Myers Squibb Compnay. Active years: 1976-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chester Sapino, Jr. Retrieved from https://idiyas.com/inventor/chester-sapino-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 87(Granted Patents)


Location History:

  • E. Syracuse, NY (US) (1991)
  • East Syracuse, NY (US) (1976 - 1995)

Company Filing History:

goldMedal12 out of 637 
 
Bristol-Myers Company
 patents
silverMedal3 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents

Years Active: 1976-1995

Loading Chart...
15 patents (USPTO):Explore Patents
1. 5420269 - 3-fluorosulfonyloxyceph-3-em compounds (1995-05-30),
2. 5245027 - 3-fluorosulfonyloxyceph-3-em compounds (1993-09-14),
3. 5043439 - Process for production of cephalosporins (1991-08-27),
4. 4879377 - Nucleoside process (1989-11-07),
5. 4870168 - 3-Unsaturated alkyl cephems from 3-triflyl cephems (1989-09-26),
6. 4847373 - Production of 3-allyl- and 3-butenyl-3-cephems (1989-07-11),
7. 4625020 - Nucleoside process (1986-11-25),
8. 4351766 - Production of penicillins (1982-09-28),
9. 4316017 - Cephalosporin intermediates (1982-02-16),
10. 4316016 - Cephalosporin intermediates (1982-02-16),
11. 4310458 - Production of penicillins (1982-01-12),
12. 4278600 - Production of penicillins (1981-07-14),
13. 4240960 - Trimethylsilyl substituted penicillins (1980-12-23),
14. 4223135 - Production of cephalosporins (1980-09-16),
15. 3932392 - Process for the preparation of 7-aminocephalosporanic acids (1976-01-13),

Title: Chester Sapino, Jr.: Pioneering Innovations in Pharmaceuticals

Introduction:

Chester Sapino, Jr., a prolific inventor hailing from East Syracuse, NY, has made significant contributions to the field of pharmaceuticals. With an impressive portfolio of 15 patents, Sapino's groundbreaking work has led to advancements in drug development and synthesis.

Latest Patents:

Among his latest patents is the innovative work on 3-fluorosulfonyloxyceph-3-em compounds. These compounds, with a protected amino or acylamino group in the 7-position, undergo carbon-carbon bond formation at the 3-position through a palladium-catalyzed coupling reaction with substituted organostannanes. Additionally, Sapino has disclosed a process for preparing cefprozil, a crucial antibiotic in the medical field.

Career Highlights:

Sapino has left an indelible mark on the pharmaceutical industry through his tenure at renowned companies such as Bristol-Myers Company and Bristol-Myers Squibb Company. His expertise and innovative mindset have played a pivotal role in shaping the landscape of drug discovery and development.

Collaborations:

Throughout his career, Sapino has collaborated with esteemed professionals in the field. Some of his notable coworkers include David A. Johnson and Derek Walker. Together, they have worked on projects that have pushed the boundaries of pharmaceutical research and development.

Conclusion:

In conclusion, Chester Sapino, Jr.'s unwavering dedication to innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the pharmaceutical industry. His groundbreaking inventions continue to pave the way for future advancements in drug synthesis and treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…